UV/visible Spectroscopy in the Development of Biopharmaceuticals
List Feb 18, 2020 | By Rachel Murkett
Biopharmaceuticals represent an entirely new generation of human therapeutics. However, due to their inherent complexity, biopharmaceuticals require sensitive, well-established and efficient methods of characterization in order to optimize their safety and efficacy.
In this list, discover how ultraviolet/visible (UV/vis) spectroscopy rises to the challenges of biopharmaceutical development and manufacturing processes, including:
- Determining concentration
- Monitoring intermolecular interactions
The world is facing a health crisis of an unprecedented scale. The COVID-19 outbreak, caused by the SARS-CoV-2 virus, has rapidly spread across the globe and caused thousands of deaths. In this list, we highlight the efforts of five healthcare companies working to tackle the outbreak of COVID-19.READ MORE
The host systems often used to manufacture protein-based biotherapeutics can produce their own endogenous proteins, known as host cell proteins (HCPs), which can ultimately contaminate the product. Download this list to learn about some of the most commonly used methods for HCP analysis.READ MORE